High-physiological and supra-physiological 1,2-13C2 glucose focal supplementation to the traumatised human brain.

Published version
Repository DOI

Change log
Authors
Howe, Duncan J 
Thelin, Eric P 
Jalloh, Ibrahim 
Abstract

How to optimise glucose metabolism in the traumatised human brain remains unclear, including whether injured brain can metabolise additional glucose when supplied. We studied the effect of microdialysis-delivered 1,2-13C2 glucose at 4 and 8 mmol/L on brain extracellular chemistry using bedside ISCUSflex, and the fate of the 13C label in the 8 mmol/L group using high-resolution NMR of recovered microdialysates, in 20 patients. Compared with unsupplemented perfusion, 4 mmol/L glucose increased extracellular concentrations of pyruvate (17%, p = 0.04) and lactate (19%, p = 0.01), with a small increase in lactate/pyruvate ratio (5%, p = 0.007). Perfusion with 8 mmol/L glucose did not significantly influence extracellular chemistry measured with ISCUSflex, compared to unsupplemented perfusion. These extracellular chemistry changes appeared influenced by the underlying metabolic states of patients' traumatised brains, and the presence of relative neuroglycopaenia. Despite abundant 13C glucose supplementation, NMR revealed only 16.7% 13C enrichment of recovered extracellular lactate; the majority being glycolytic in origin. Furthermore, no 13C enrichment of TCA cycle-derived extracellular glutamine was detected. These findings indicate that a large proportion of extracellular lactate does not originate from local glucose metabolism, and taken together with our earlier studies, suggest that extracellular lactate is an important transitional step in the brain's production of glutamine.

Description

Peer reviewed: True

Keywords
1,2-13C2 glucose, Brain metabolism, NMR, microdialysis, traumatic brain injury (human), Humans, Glucose, Glutamine, Brain, Microdialysis, Lactic Acid, Pyruvic Acid, Dietary Supplements
Journal Title
J Cereb Blood Flow Metab
Conference Name
Journal ISSN
0271-678X
1559-7016
Volume Title
43
Publisher
SAGE Publications
Sponsorship
Cambridge University Hospitals NHS Foundation Trust (CUH) (unknown)
Cambridge University Hospitals NHS Foundation Trust (CUH) (146281)
Medical Research Council (G1002277)
Medical Research Council (G0600986)
Medical Research Council (G0802251)
Wellcome Trust (220257/Z/20/Z)
The authors gratefully acknowledge receipt of the following financial support for the research, authorship, and/or publication of this article: Medical Research Council (Grant Nos. G0600986 ID79068 and G1002277 ID98489) and National Institute for Health Research Biomedical Research Centre, Cambridge (Neuroscience Theme; Brain Injury and Repair Theme). Authors’ support: MGS – National Institute for Health Research Biomedical Research Centre, Cambridge; Cambridge; EPT – Strategic Research Area for Neuroscience (StratNeuro, Karolinska Institutet), The Erling-Persson Family Foundation, Region Stockholm (Clinical Research Appointment) and the Swedish Brain Foundation (#FO2019-0006); KLHC – National Institute for Health and Care Research (NIHR) Biomedical Research Centre, Cambridge (Neuroscience Theme; Brain Injury and Repair Theme), by an NIHR i4i Challenge Award II-C5-0715- 20005, an NIHR i4i Product Development Award NIHR200986, and the NIHR Brain Injury MedTech Co-operative; CG – the Canadian Institute of Health Research; AH - Medical Research Council/Royal College of Surgeons of England Clinical Research Training Fellowship (Grant no. G0802251), Royal College of Surgeons of England Pump Priming Grant; DKM – National Institute for Health Research Senior Investigator Awards; PJH – National Institute for Health Research Professorship, Academy of Medical Sciences/Health Foundation Senior Surgical Scientist Fellowship and the National Institute for Health and Care Research Biomedical Research Centre, Cambridge. MPM - Medical Research Council UK (MC_UU_00028/4) and a Wellcome Trust Investigator award (220257/Z/20/Z). The views expressed in this paper are those of the Authors and are not necessarily those of the NIHR or any of the other funding bodies.